Gottlieb, A., Gisondi, P., Eells, J., Peterson, L., & Kavanaugh, A. (2020). Durability of Response in Patients with Psoriatic Arthritis Treated with Certolizumab Pegol over 216 Weeks: Post-Hoc Analyses from the RAPID-PsA Study. SKIN The Journal of Cutaneous Medicine, 4(1), S2. Retrieved from https://jofskin.org/33014/index.php/skin/article/view/801